Related Experiment Videos
How individual sensitivity to opiates can be predicted by gene analyses
Kazutaka Ikeda1, Soichiro Ide, Wenhua Han
1Department of Molecular Psychiatry, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan. ikedak@prit.go.jp
Trends in Pharmacological Sciences
|June 1, 2005
Summary
Genetic variations in the OPRM1 gene influence how individuals respond to opioid pain relievers. Understanding these genetic differences can help predict pain relief needs and reduce risks associated with opioid abuse.
Area of Science:
- Pharmacogenomics
- Neuroscience
- Genetics
Background:
- Opioid analgesics are crucial for pain management but exhibit variable efficacy and abuse potential.
- Individual differences in opioid sensitivity pose challenges for effective pain treatment and addiction prevention.
- Genetic factors are suspected to underlie these individual variations, but specific mechanisms remain underexplored.
Purpose of the Study:
- To investigate the role of the OPRM1 gene and its polymorphisms in determining individual sensitivity to opioid analgesics.
- To elucidate the relationship between OPRM1 gene variations, MOP receptor function, and responses to opiates.
- To explore the potential of genetic information for personalized pain management and addiction risk assessment.
Main Methods:
- Review of recent studies utilizing inbred and knockout mouse models to assess the function of the mu opioid peptide (MOP) receptor.
- Analysis of identified polymorphisms in the human OPRM1 gene and their correlation with opioid sensitivity and drug dependence.
- Examination of the impact of OPRM1 gene sequence variations on OPRM1 mRNA levels and MOP receptor expression.
Main Results:
- The mu opioid peptide (MOP) receptor, encoded by the Oprm1 gene, plays a critical role in mediating both analgesic and addictive effects of opioids.
- Evidence indicates that variations in Oprm1 gene sequences alter OPRM1 mRNA levels, influencing opioid sensitivity.
- >100 polymorphisms in the human OPRM1 gene have been identified, with some linked to increased vulnerability to drug dependence in specific populations.
Conclusions:
- The OPRM1 gene and its polymorphisms are significant determinants of individual differences in opioid sensitivity.
- Understanding the genetic basis of opioid response can lead to more precise predictions of patient sensitivity and required dosages.
- Advances in this field pave the way for personalized medicine approaches in pain management and addiction treatment, optimizing therapeutic outcomes and mitigating risks.